134 related articles for article (PubMed ID: 10556216)
21. Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma.
M'kacher R; Bennaceur A; Farace F; Laugé A; Plassa LF; Wittmer E; Dossou J; Violot D; Deutsch E; Bourhis J; Stoppa-Lyonnet D; Ribrag V; Carde P; Parmentier C; Bernheim A; Turhan AG
Oncogene; 2003 Sep; 22(39):7905-12. PubMed ID: 12970738
[TBL] [Abstract][Full Text] [Related]
22. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
Mareckova A; Malcikova J; Tom N; Pal K; Radova L; Salek D; Janikova A; Moulis M; Smardova J; Kren L; Mayer J; Trbusek M
Leuk Lymphoma; 2019 Jun; 60(6):1420-1428. PubMed ID: 30626249
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of deletion at 11q22.1-23.3 in mantle cell lymphoma.
Monni O; Zhu Y; Franssila K; Oinonen R; Höglund P; Elonen E; Joensuu H; Knuutila S
Br J Haematol; 1999 Mar; 104(4):665-71. PubMed ID: 10192424
[TBL] [Abstract][Full Text] [Related]
24. Characterization of genetic changes in MCL by interphase FISH on tissue sections.
Sander B; Wallblom A; Ekroth A; Porwit A; Kimby E
Leuk Lymphoma; 2007 Jul; 48(7):1344-52. PubMed ID: 17613764
[TBL] [Abstract][Full Text] [Related]
25. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
26. CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas.
Tort F; Hernàndez S; Beà S; Martínez A; Esteller M; Herman JG; Puig X; Camacho E; Sánchez M; Nayach I; Lopez-Guillermo A; Fernández PL; Colomer D; Hernàndez L; Campo E
Blood; 2002 Dec; 100(13):4602-8. PubMed ID: 12393693
[TBL] [Abstract][Full Text] [Related]
27. ATM gene deletion in patients with adult acute lymphoblastic leukemia.
Haidar MA; Kantarjian H; Manshouri T; Chang CY; O'Brien S; Freireich E; Keating M; Albitar M
Cancer; 2000 Mar; 88(5):1057-62. PubMed ID: 10699895
[TBL] [Abstract][Full Text] [Related]
28. Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases.
Rodriguez C; Vallès H; Causse A; Johannsdottir V; Eliaou JF; Theillet C
Genes Chromosomes Cancer; 2002 Feb; 33(2):141-9. PubMed ID: 11793440
[TBL] [Abstract][Full Text] [Related]
29. Development of a mantle cell lymphoma in an ATM heterozygous woman after occupational exposure to ionising radiation and somatic mutation of the second allele.
Briani C; Schlotter M; Lichter P; Kalla C
Leuk Res; 2006 Sep; 30(9):1193-6. PubMed ID: 16387360
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
[TBL] [Abstract][Full Text] [Related]
31. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
[TBL] [Abstract][Full Text] [Related]
32. PPP2R1B gene in chronic lymphocytic leukemias and mantle cell lymphomas.
Zhu Y; Loukola A; Monni O; Kuokkanen K; Franssila K; Elonen E; Vilpo J; Joensuu H; Kere J; Aaltonen L; Knuutila S
Leuk Lymphoma; 2001 Mar; 41(1-2):177-83. PubMed ID: 11342371
[TBL] [Abstract][Full Text] [Related]
33. Ataxia-telangiectasia locus: sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene.
Platzer M; Rotman G; Bauer D; Uziel T; Savitsky K; Bar-Shira A; Gilad S; Shiloh Y; Rosenthal A
Genome Res; 1997 Jun; 7(6):592-605. PubMed ID: 9199932
[TBL] [Abstract][Full Text] [Related]
34. Disruption of the ATM gene in breast cancer.
Lu Y; Condie A; Bennett JD; Fry MJ; Yuille MR; Shipley J
Cancer Genet Cytogenet; 2001 Apr; 126(2):97-101. PubMed ID: 11376801
[TBL] [Abstract][Full Text] [Related]
35. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
36. Phenotypic correction of ataxia-telangiectasia cellular defect by exogenously introduced human or mouse subchromosomal fragments.
Ejima Y; Sasaki MS
Somat Cell Mol Genet; 1997 Sep; 23(5):341-51. PubMed ID: 9546077
[TBL] [Abstract][Full Text] [Related]
37. Mantle cell lymphoma: a biological and therapeutic paradigm.
Decaudin D
Leuk Lymphoma; 2002 Apr; 43(4):773-81. PubMed ID: 12153164
[TBL] [Abstract][Full Text] [Related]
38. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
[TBL] [Abstract][Full Text] [Related]
39. ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.
Rose-Zerilli MJ; Forster J; Parker H; Parker A; Rodríguez AE; Chaplin T; Gardiner A; Steele AJ; Collins A; Young BD; Skowronska A; Catovsky D; Stankovic T; Oscier DG; Strefford JC
Haematologica; 2014 Apr; 99(4):736-42. PubMed ID: 24584352
[TBL] [Abstract][Full Text] [Related]
40. ATM mutation and radiosensitivity: An opportunity in the therapy of mantle cell lymphoma.
Ahmed M; Li L; Pinnix C; Dabaja B; Nomie K; Lam L; Wang M
Crit Rev Oncol Hematol; 2016 Nov; 107():14-19. PubMed ID: 27823642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
